+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Synthon International Holdings BV - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 25 Pages
  • March 2026
  • Region: Global
  • GlobalData
  • ID: 5397257
Synthon International Holdings BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Report Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Synthon International Holdings BV (Synthon) develops and manufactures complex generic pharmaceuticals. The company focuses on producing pharmaceutical products, including tablets, capsules, granulates, syringes, vials, and semi-solids. The company undertakes the research, development, manufacture, and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal, and urology. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina, South Korea, and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Synthon International Holdings BV - Key Facts
  • Synthon International Holdings BV - Key Employees
  • Synthon International Holdings BV - Major Products and Services
  • Synthon International Holdings BV - History
  • Synthon International Holdings BV - Company Statement
  • Synthon International Holdings BV - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Synthon International Holdings BV - Business Description
  • Synthon International Holdings BV - SWOT Analysis
  • SWOT Analysis - Overview
  • Synthon International Holdings BV - Strengths
  • Synthon International Holdings BV - Weaknesses
  • Synthon International Holdings BV - Opportunities
  • Synthon International Holdings BV - Threats
  • Synthon International Holdings BV - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Synthon International Holdings BV, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Synthon International Holdings BV, Key Facts
  • Synthon International Holdings BV, Key Employees
  • Synthon International Holdings BV, Major Products and Services
  • Synthon International Holdings BV, History
  • Synthon International Holdings BV, Subsidiaries
  • Synthon International Holdings BV, Key Competitors
  • Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Synthon International Holdings BV, Recent Deals Summary
List of Figures
  • Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ranbaxy Netherlands BV
  • Nexins Research BV
  • Esperante Development BV
  • Truvion Healthcare BV
  • Zentiva NV